The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. (Q47900047)

6 February 2018

title

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. (English)

1 reference

6 February 2018

gastroesophageal reflux disease

main subject

seroprevalence

0 references

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

3

1 reference

6 February 2018

Kirk Easley

5

1 reference

6 February 2018

Martin J. Blaser

10

object named as

Blaser MJ

1 reference

PubMed ID

9649458

6 February 2018

Guillermo I Perez Perez

7

object named as

Perez-Perez GI

1 reference

6 February 2018

author name string

Vicari JJ

1

1 reference

6 February 2018

Peek RM

2

1 reference

6 February 2018

Goldblum JR

4

1 reference

6 February 2018

Schnell J

6

1 reference

6 February 2018

Halter SA

8

1 reference

6 February 2018

Rice TW

9

1 reference

6 February 2018

Richter JE

11

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

published in

Gastroenterology

1 reference

6 February 2018

volume

115

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

50-57

1 reference

6 February 2018

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Helicobacter pylori infection and chronic gastric acid hyposecretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Helicobacter pylori and gastro-oesophageal reflux disease--a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Patterns of colonisation of Campylobacter pylori in the oesophagus, stomach and duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Campylobacter pylori and Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Symptoms in gastro-oesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

The increasing frequency of adenocarcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Relation between gastric cancer and previous peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Helicobacter pylori and gastric acid: biological and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Helicobacter pylori and atrophic gastritis: importance of the cagA status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970364-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(98)70364-6

1 reference

6 February 2018

PubMed ID

9649458

1 reference

6 February 2018